Insider Transactions Reported by 22 Insiders of Horizon Therapeutics Public Ltd Co

Industry
Pharmaceutical Preparations
Location
Dublin, Ireland

There are no Buy or Sell transactions made by insiders since 12/15/2024

Horizon Therapeutics Public Ltd Co executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Paul W. Hoelscher Evp, Cfo $16.4M Apr 20, 2022
Barry Moze EVP, Chief Admin. Officer $16.1M Jan 5, 2022
Jeff Kent Officer $9.74M May 11, 2021
Brian K. Beeler EVP, General Counsel $7.31M Sep 17, 2021
Miles W. McHugh Sr VP & Princ. Acctg Officer $5.43M Jan 4, 2022
Michael A. DesJardin EVP, Technical Operations Oct 6, 2023
Andy Pasternak EVP, Chief Strategy Officer Oct 6, 2023
Sean M. Clayton EVP, General Counsel Oct 6, 2023
Pascale Witz Director Oct 6, 2023
Aaron Cox EVP, Chief Financial Officer Oct 6, 2023
Jeffrey W. Sherman EVP and Chief Medical Officer Oct 6, 2023
Patrick McIlvenny Chief Accounting Officer Oct 6, 2023
Thomas Watkins Director Oct 6, 2023
Timothy P. Walbert Chairman, President and CEO, Director Oct 6, 2023
Susan Mahony Director Oct 6, 2023
William F. Daniel Director Oct 6, 2023
H.Z. Thompson EVP, Research & Development Oct 6, 2023
Jacopo Leonardi Pres., Global Commercial Ops Jun 1, 2022
Michael G. Grey Director Oct 6, 2023
Gino Santini Director Oct 6, 2023
Jeff Himawan Director Oct 6, 2023
James Samuel Shannon Director Oct 6, 2023

Recent Insider Transactions by Companies or Individuals for Horizon Therapeutics Public Ltd Co

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.